152 related articles for article (PubMed ID: 36940202)
1. Development of a digital imaging analysis system to evaluate the treatment response in superficial infantile hemangiomas.
Xie M; Liu J; Zhou P; Xu X; Liu H; Zeng L; Chen F; Zeng Y; Huang H; Peng W; Xiao H; Liu Q
PLoS One; 2023; 18(3):e0282274. PubMed ID: 36940202
[TBL] [Abstract][Full Text] [Related]
2. Colorimetric analysis of images in the follow-up of infantile hemangiomas.
Abagge KT; Sandri CO; Sakai LSM; Mussato LP; Petterle RR; Oliveira de Carvalho VO
Pediatr Dermatol; 2020 Jul; 37(4):622-625. PubMed ID: 32202335
[TBL] [Abstract][Full Text] [Related]
3. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
4. Growth characteristics of infantile hemangiomas: implications for management.
Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
[TBL] [Abstract][Full Text] [Related]
5. Infantile hemangiomas with minimal or arrested growth: A retrospective case series.
Martin JM; Sanchez S; González V; Cordero P; Ramon D
Pediatr Dermatol; 2019 Jan; 36(1):125-131. PubMed ID: 30318787
[TBL] [Abstract][Full Text] [Related]
6. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas.
Poetke M; Philipp C; Berlien HP
Arch Dermatol; 2000 May; 136(5):628-32. PubMed ID: 10815856
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy.
Baselga E; Roe E; Coulie J; Muñoz FZ; Boon LM; McCuaig C; Hernandez-Martín A; Gich I; Puig L
JAMA Dermatol; 2016 Nov; 152(11):1239-1243. PubMed ID: 27540637
[TBL] [Abstract][Full Text] [Related]
8. Analysis of lesional color to differentiate infantile hemangiomas from port-wine birthmarks in infants less than 3 months old: A pilot study.
O'Brien KF; Frieden IJ; Zeymo A; Vasic J; Silverman R; Goldberg G; Carver DeKlotz CM
Pediatr Dermatol; 2021 May; 38(3):585-590. PubMed ID: 33742460
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
[TBL] [Abstract][Full Text] [Related]
10. Predictors of treatment responses of superficial infantile hemangiomas to topical timolol.
Zheng H; Cai Y; Xu Y; Yu Q; Kang B; Chen C; Gong X; Li W
Dermatol Ther; 2022 Nov; 35(11):e15833. PubMed ID: 36106484
[TBL] [Abstract][Full Text] [Related]
11. Infantile hemangiomas with minimal or arrested growth: a retrospective case series.
Suh KY; Frieden IJ
Arch Dermatol; 2010 Sep; 146(9):971-6. PubMed ID: 20855695
[TBL] [Abstract][Full Text] [Related]
12. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
Ho NT; Lansang P; Pope E
J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
[TBL] [Abstract][Full Text] [Related]
13. Skin sequelae in patients with infantile hemangioma: a systematic review.
Li W; Kang J; Bai S; Yuan L; Liu J; Bi Y; Sun J; He Y
Eur J Pediatr; 2023 Feb; 182(2):479-488. PubMed ID: 36434402
[TBL] [Abstract][Full Text] [Related]
14. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
[TBL] [Abstract][Full Text] [Related]
15. Infantile Hemangioma: An Updated Review.
Leung AKC; Lam JM; Leong KF; Hon KL
Curr Pediatr Rev; 2021; 17(1):55-69. PubMed ID: 32384034
[TBL] [Abstract][Full Text] [Related]
16. Segmental hemangioma of infancy complicated by life-threatening arterial bleed.
Connelly EA; Viera M; Price C; Waner M
Pediatr Dermatol; 2009; 26(4):469-72. PubMed ID: 19689527
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
18. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
Kagami S; Kaneko M; Kishi A; Katori T
J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
[TBL] [Abstract][Full Text] [Related]
19. The dermoscopic features in infantile hemangioma.
Oiso N; Kawada A
Pediatr Dermatol; 2011; 28(5):591-3. PubMed ID: 21854412
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
